Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia

Jae Hung Jung, Roderick Macdonald, Jiye Kim, Myung Ha Kim, Philipp Dahm

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and adverse effects of silodosin compared to placebo or other medical treatments in men with LUTS suggestive of BPH.

Original languageEnglish (US)
Article numberCD012615
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number3
DOIs
StatePublished - Mar 28 2017

Bibliographical note

Publisher Copyright:
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia'. Together they form a unique fingerprint.

Cite this